Latest headlines

Bristol Myers Squibb News

Q: Why is Bristol Myers Squibb up or down today?

Bristol Myers Squibb (BMY) moves on news. The headlines above show what is driving BMY today; cross-check the reaction against its Fear and Greed Index and trading volume.

Q: How often is Bristol Myers Squibb news updated?

The Bristol Myers Squibb (BMY) news feed refreshes continuously as new stories are published.

Q: How does Bristol Myers Squibb news relate to its Fear and Greed Index?

News drives sentiment and sentiment drives price. Read Bristol Myers Squibb news alongside its Fear and Greed Index to separate noise from a real shift in mood.

The latest Bristol Myers Squibb (BMY) news, aggregated as it breaks. News moves sentiment and sentiment moves price, so read these BMY headlines next to the live Bristol Myers Squibb Fear and Greed Index.

Latest Bristol Myers Squibb Headlines60

Start Investing At 60 And Retire On Dividends Forever

seekingalpha.com · Jul 10, 2026

2 Dirt Cheap Dividend Stocks to Buy With $1,000 Right Now

fool.com · Jul 7, 2026

3 High-Yield Dividend Stocks to Buy and Hold Forever (Hint: AbbVie Makes the List)

fool.com · Jul 7, 2026

Is Bristol Myers Squibb's 4.3% Dividend Yield Safe? Here's What Investors Need to Know.

fool.com · Jul 6, 2026

Bristol Myers Squibb: Pain First, Payoff Later?

seekingalpha.com · Jul 3, 2026

Bristol-Myers Squibb: Cash Flow Machine, Outsized Growth Portfolio, And Inflation Beating Incomes

seekingalpha.com · Jul 3, 2026

Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It

zacks.com · Jul 1, 2026

Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

fool.com · Jul 1, 2026

Why Bristol Myers Squibb (BMY) is a Top Value Stock for the Long-Term

zacks.com · Jun 30, 2026

Merck, AbbVie probed by US lawmakers over China clinical trials: report

proactiveinvestors.com · Jun 30, 2026

Recursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

fool.com · Jun 30, 2026

Bristol Myers Squibb (BMY) Exceeds Market Returns: Some Facts to Consider

zacks.com · Jun 29, 2026

66 With $1.3 Million. Here Are 3 Hidden Gems to Target

247wallst.com · Jun 29, 2026

Here's Why Bristol Myers Squibb (BMY) is a Strong Momentum Stock

zacks.com · Jun 29, 2026

Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

fool.com · Jun 26, 2026

Revisiting Stock Picks Intel, Progressive, Bristol Myers Squibb

barrons.com · Jun 25, 2026

Bristol Myers Squibb (BMY) Ascends While Market Falls: Some Facts to Note

zacks.com · Jun 23, 2026

3 Reasons to Buy Bristol Myers Squibb Stock

fool.com · Jun 22, 2026

Bristol Myers Squibb to Report Results for Second Quarter 2026 on July 30, 2026

businesswire.com · Jun 18, 2026

Bristol Myers Squibb Announces Dividend

businesswire.com · Jun 17, 2026

Elicio Therapeutics Points To Durable Responses As It Maps Next Steps For Lead Cancer Drug

benzinga.com · Jun 17, 2026

The Healthcare M&A Wave

forbes.com · Jun 17, 2026

3 Stocks to Invest In to Rebalance Your Portfolio

youtube.com · Jun 17, 2026

Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know

zacks.com · Jun 17, 2026

Interest Rates Are Going Higher: 4 High-Yield Passive Income Stocks Can Weather Any Storm

247wallst.com · Jun 17, 2026

Can BMY's Camzyos Strengthen Its Cardiovascular Portfolio?

zacks.com · Jun 16, 2026

3 Dividend Stocks to Hold for the Long Haul

fool.com · Jun 16, 2026

A Dramatic Shift in Fed Policy Just Unlocked a New Era for Bristol Myers Squibb

247wallst.com · Jun 15, 2026

How Safe is Bristol Myers Squibb's Dividend? Here's My Honest Take.

fool.com · Jun 13, 2026

Can Bristol Myers' Growth Portfolio Offset Legacy Drug Declines?

zacks.com · Jun 12, 2026

Why Bristol Myers Squibb (BMY) Outpaced the Stock Market Today

zacks.com · Jun 11, 2026

Bristol Myers Squibb Dividend Raise Streak is 18 Years. Here's 1 Number That Says the Streak Will Continue.

fool.com · Jun 11, 2026

Bristol Myers Squibb (BMY) is a Top-Ranked Value Stock: Should You Buy?

zacks.com · Jun 11, 2026

Takeda's AI-crafted psoriasis pill tops Bristol Myers' Sotyktu in head-to-head trial

reuters.com · Jun 11, 2026

Bristol-Myers Squibb Company (BMY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

seekingalpha.com · Jun 9, 2026

Mariska Hargitay Partners with Bristol Myers Squibb for “Investigating Myeloma” Awareness Campaign to Honor Her Father 20 Years After Losing Him to the Disease

businesswire.com · Jun 8, 2026

Bristol Myers Squibb (BMY) Gains As Market Dips: What You Should Know

zacks.com · Jun 5, 2026

Billionaire Izzy Englander Just Made a Big Bet on This Beaten-Down High-Yield Dividend Stock

fool.com · Jun 5, 2026

Arcus, Bristol Myers Team Up to Advance Kidney Cancer Study

zacks.com · Jun 4, 2026

Better High-Yield Dividend Stock to Buy: Bristol Myers Squibb or Pfizer?

fool.com · Jun 4, 2026

Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know

zacks.com · Jun 3, 2026

Arcus Biosciences Announces Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD‑L1/VEGF‑A Bispecific Immunomodulator to Treat Kidney Cancer

businesswire.com · Jun 3, 2026

Bristol Myers vs. Pfizer: Which High‑Yield Dividend Stock Wins Now?

fool.com · Jun 3, 2026

Recursion Pharmaceuticals vs. Schrödinger: Which Healthcare Stock Is a Better Buy in 2026?

fool.com · Jun 2, 2026

BMY Gets Opdivo Label Expansion in the EU, Update on Camzyos

zacks.com · Jun 2, 2026

Bristol Myers Squibb: This Pullback Is A Gift For Long-Term Investors

seekingalpha.com · Jun 2, 2026

Izalontamab Brengitecan (Iza-Bren) Demonstrates Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Patients with Triple-Negative Breast Cancer and Esophageal Squamous Cell Carcinoma

businesswire.com · Jun 2, 2026

Bristol Myers' Growth Portfolio Just Overtook The Legacy One

seekingalpha.com · Jun 2, 2026

Why Bristol Myers Squibb Stock Isn't Nearly As Cheap As It Looks

fool.com · Jun 1, 2026

Bristol Myers Showcases Data on MM and NSCLC Drugs at ASCO

zacks.com · Jun 1, 2026

U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb's Supplemental New Drug Application for Camzyos (mavacamten) to Treat Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)

businesswire.com · Jun 1, 2026

Bristol Myers Squibb Announces Opdivo® (nivolumab) in Combination with AVD Receives Expanded EU Label with Approval in Frontline Advanced Classical Hodgkin Lymphoma

businesswire.com · Jun 1, 2026

Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial

globenewswire.com · May 30, 2026

Globale Daten der ROSETTA Lung-02-Studie: Ermutigende Wirksamkeit für BioNTechs und Bristol Myers Squibbs bispezifischen PD-L1xVEGF-A-Immunmodulator-Kandidat Pumitamig bei nicht-kleinzelligem Lungenkrebs

globenewswire.com · May 30, 2026

Bristol Myers drug delays myeloma progression in hard to treat patients

reuters.com · May 29, 2026

How Bristol Is Building On Its $74 Billion Celgene Buyout With New 'Molecular Glue'

investors.com · May 29, 2026

Bristol Myers Squibb Announces CELMoD Mezigdomide Reduces Risk of Disease Progression or Death by More than 50% vs. Standard of Care in Relapsed or Refractory Multiple Myeloma

businesswire.com · May 29, 2026

Bristol-Myers Squibb Is Quietly Building Its Next Growth Cycle

seekingalpha.com · May 27, 2026

Bristol Myers Squibb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

businesswire.com · May 27, 2026

Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock

zacks.com · May 26, 2026

Why Is Bristol Myers Squibb Up or Down Today?

When Bristol Myers Squibb (BMY) moves sharply, the reason is almost always in the headlines above. Earnings, guidance, analyst upgrades and downgrades, product news and macro data are the usual drivers of a BMY move on the day. The feed shows what broke and when, and the sentiment tag on each story shows whether the coverage skews positive or negative, so you can see at a glance why Bristol Myers Squibb is up or down today.

How Bristol Myers Squibb News Affects the Price

News does not move the Bristol Myers Squibb (BMY) price directly, it moves sentiment, and sentiment moves price. A run of negative headlines pulls the Bristol Myers Squibb Fear and Greed Index toward fear, while positive coverage pushes it toward greed, often before the price has fully reacted. A surprise story usually shows up first as a spike in Bristol Myers Squibb trading volume. That is the chain to watch: headline, sentiment, volume, then the BMY price.

Trade the Bristol Myers Squibb News With Sentiment

Headlines tell you what happened; the Fear and Greed Index tells you how the crowd is reacting. Watch Bristol Myers Squibb trading volume spike on a big story, check the Bristol Myers Squibb price history for context, follow the live BMY price, see the Bristol Myers Squibb price prediction, and read the Bristol Myers Squibb Fear and Greed Index for mood.

How do you feel about Bristol Myers Squibb?

Frequently asked questions

Why is Bristol Myers Squibb up or down today?

Bristol Myers Squibb (BMY) moves on news, and the headlines above are the fastest way to see what is driving BMY today, from earnings, guidance and analyst moves to the broader market mood. Cross-check the reaction against the live Bristol Myers Squibb Fear and Greed Index and BMY trading volume.

What is the latest Bristol Myers Squibb news?

The newest Bristol Myers Squibb (BMY) headlines are listed above, most recent first, each linking to the original source. We pull the last 60 stories so you can scroll the full recent BMY news cycle in one place.

Where does Bristol Myers Squibb news come from?

We aggregate Bristol Myers Squibb (BMY) headlines from financial news wires and refresh them continuously. Each headline links straight to the original source.

How often is Bristol Myers Squibb news updated?

Continuously. The Bristol Myers Squibb (BMY) feed refreshes as new stories are published, so the headlines at the top are the freshest available.

How does Bristol Myers Squibb news relate to its Fear and Greed Index?

News drives sentiment, and sentiment drives price. A run of negative headlines tends to push the Bristol Myers Squibb Fear and Greed Index toward fear, positive coverage toward greed. Reading them together is how you separate noise from a real shift in mood.

Headlines are aggregated from third-party sources and link to the original publishers. CFGI does not author or endorse them.

About CFGI

The per-asset sentiment record.

CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.

Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.